ENTX
NASDAQ · Biotechnology
Entera Bio Ltd
$2.69
-0.06 (-2.00%)
Open$2.80
Previous Close$2.75
Day High$2.89
Day Low$2.65
52W High$4.20
52W Low$0.91
Volume—
Avg Volume405.6K
Market Cap479.78M
P/E Ratio—
EPS$-0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,519.7% upside
Current
$2.69
$2.69
Target
$43.57
$43.57
$34.30
$43.57 avg
$49.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 157.3K | 229.2K | 9.20M |
| Net Income | -43,276,558 | -56,760,277 | -2,830,498 |
| Profit Margin | -27,235.7% | -25,873.9% | -30.8% |
| EBITDA | -43,503,778 | -60,228,197 | -2,581,372 |
| Free Cash Flow | — | — | -3,568,526 |
| Rev Growth | -31.4% | -31.4% | +9.2% |
| Debt/Equity | — | — | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |